Collegium Pharmaceutical, Inc. COLL Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s operating cash flow?
- Collegium Pharmaceutical, Inc. (COLL) reported operating cash flow of $57.11M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s operating cash flow changed year-over-year?
- Collegium Pharmaceutical, Inc.'s operating cash flow increased by 3.1% year-over-year, from $55.4M to $57.11M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s operating cash flow has grown at a 33.5% compound annual growth rate (CAGR), from $103.56M to $329.32M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.